From January 1 onwards, a medication relied upon by numerous patients for respiratory support will no longer be available in pharmacies. Physicians express worry over potential delays as patients transition to alternative treatments and navigate the process of securing insurance coverage for these alternatives.
Posted on December 29, 2023
Recent Posts
Hacking and Healing: Nation-States, Cyber Attacks, and Healthcare LawReproductive Rights Attorney: This Is Why Right-Wing Interest Are Attempting To Ban MifepristoneDecades in the Making: 42 CFR Part 2’s Transformation After 50 YearsHarry Nelson on Forbes News: Impact of the Alabama Supreme Court’s Frozen Embryo RulingCalifornia’s Corporate Healthcare Law, Practice of Medicine (CPOM)
Related Attorneys
Harry Nelson